ctDNA-based next-generation sequencing in 236 patients with advanced breast cancer revealed frequent PIK3CA, TP53, and ESR1 mutations, highlighting key mechanisms of endocrine resistance with implications for targeted therapy selection.
Heidi C. Ko
Advertisement
Articles by Heidi C. Ko
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
ctDNA MRD Guidance in Bladder Cancer: Pharmacy Specialist on NCCN Updates
2
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer
3
All-Oral AML Regimen Eases Burden on Busy Infusion Centers
4
DEC-C Plus Venetoclax May Quickly Replace IV HMA Regimens in AML
5